Jupiter Endovascular is a medical technology startup developing the endoportal procedure, a new class of endovascular procedures using Endoportal ControlTM to bring the precision and control of direct surgical access to catheter-based interventions. The procedure uses an endoportal device that navigates flexibly through the vasculature via percutaneous access. Once in position, the endoportal device can be fixed into a stable state to deliver an interventional treatment with surgical-like precision and control from an endovascular access point.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 08/15/24 | $21,000,000 | Seed |
Sonder Capital | undisclosed |
